[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Immunohistochemistry (IHC) Testing Market - Global Outlook and Forecast 2021-2027

April 2021 | 106 pages | ID: I976FBD18C16EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Immunohistochemistry (IHC) Testing in Global, including the following market information:

Global Immunohistochemistry (IHC) Testing Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Immunohistochemistry (IHC) Testing market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immunohistochemistry (IHC) Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Immunohistochemistry (IHC) Testing Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Immunohistochemistry (IHC) Testing Market Segment Percentages, By Type, 2020 (%)
  • Traditional Direct Method
  • New Direct Method
  • Enzyme Bridgemethod
  • PAP Method
China Immunohistochemistry (IHC) Testing Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Immunohistochemistry (IHC) Testing Market Segment Percentages, By Application, 2020 (%)
  • Hospital
  • Research Institute
  • Corporation
  • Other
Global Immunohistochemistry (IHC) Testing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Immunohistochemistry (IHC) Testing Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Immunohistochemistry (IHC) Testing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Immunohistochemistry (IHC) Testing Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • University of Texas MD Anderson Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • Mayo Clinic
  • Johns Hopkins Hospital
  • Cleveland Clinic
  • Dana-Farber/Brigham and Women's Cancer Center
  • Cedars-Sinai Medical Center
  • Northwestern Memorial Hospital
  • Seattle Cancer Care Alliance/University of Washington Medical Center
  • University of California San Francisco Medical Center
  • CancerResearchUK
  • Pfizer
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 RNA Probe Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global RNA Probe Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RNA PROBE OVERALL MARKET SIZE

2.1 Global RNA Probe Market Size: 2021 VS 2027
2.2 Global RNA Probe Revenue, Prospects & Forecasts: 2016-2027
2.3 Global RNA Probe Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top RNA Probe Players in Global Market
3.2 Top Global RNA Probe Companies Ranked by Revenue
3.3 Global RNA Probe Revenue by Companies
3.4 Global RNA Probe Sales by Companies
3.5 Global RNA Probe Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 RNA Probe Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers RNA Probe Product Type
3.8 Tier 1, Tier 2 and Tier 3 RNA Probe Players in Global Market
  3.8.1 List of Global Tier 1 RNA Probe Companies
  3.8.2 List of Global Tier 2 and Tier 3 RNA Probe Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global RNA Probe Market Size Markets, 2021 & 2027
  4.1.2 cRNA Probe
  4.1.3 Single-stranded cDNA Probe
  4.1.4 Oligonucleotide Probe
4.2 By Type - Global RNA Probe Revenue & Forecasts
  4.2.1 By Type - Global RNA Probe Revenue, 2016-2021
  4.2.2 By Type - Global RNA Probe Revenue, 2022-2027
  4.2.3 By Type - Global RNA Probe Revenue Market Share, 2016-2027
4.3 By Type - Global RNA Probe Sales & Forecasts
  4.3.1 By Type - Global RNA Probe Sales, 2016-2021
  4.3.2 By Type - Global RNA Probe Sales, 2022-2027
  4.3.3 By Type - Global RNA Probe Sales Market Share, 2016-2027
4.4 By Type - Global RNA Probe Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global RNA Probe Market Size, 2021 & 2027
  5.1.2 Research
  5.1.3 Monitor
5.2 By Application - Global RNA Probe Revenue & Forecasts
  5.2.1 By Application - Global RNA Probe Revenue, 2016-2021
  5.2.2 By Application - Global RNA Probe Revenue, 2022-2027
  5.2.3 By Application - Global RNA Probe Revenue Market Share, 2016-2027
5.3 By Application - Global RNA Probe Sales & Forecasts
  5.3.1 By Application - Global RNA Probe Sales, 2016-2021
  5.3.2 By Application - Global RNA Probe Sales, 2022-2027
  5.3.3 By Application - Global RNA Probe Sales Market Share, 2016-2027
5.4 By Application - Global RNA Probe Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global RNA Probe Market Size, 2021 & 2027
6.2 By Region - Global RNA Probe Revenue & Forecasts
  6.2.1 By Region - Global RNA Probe Revenue, 2016-2021
  6.2.2 By Region - Global RNA Probe Revenue, 2022-2027
  6.2.3 By Region - Global RNA Probe Revenue Market Share, 2016-2027
6.3 By Region - Global RNA Probe Sales & Forecasts
  6.3.1 By Region - Global RNA Probe Sales, 2016-2021
  6.3.2 By Region - Global RNA Probe Sales, 2022-2027
  6.3.3 By Region - Global RNA Probe Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America RNA Probe Revenue, 2016-2027
  6.4.2 By Country - North America RNA Probe Sales, 2016-2027
  6.4.3 US RNA Probe Market Size, 2016-2027
  6.4.4 Canada RNA Probe Market Size, 2016-2027
  6.4.5 Mexico RNA Probe Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe RNA Probe Revenue, 2016-2027
  6.5.2 By Country - Europe RNA Probe Sales, 2016-2027
  6.5.3 Germany RNA Probe Market Size, 2016-2027
  6.5.4 France RNA Probe Market Size, 2016-2027
  6.5.5 U.K. RNA Probe Market Size, 2016-2027
  6.5.6 Italy RNA Probe Market Size, 2016-2027
  6.5.7 Russia RNA Probe Market Size, 2016-2027
  6.5.8 Nordic Countries RNA Probe Market Size, 2016-2027
  6.5.9 Benelux RNA Probe Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia RNA Probe Revenue, 2016-2027
  6.6.2 By Region - Asia RNA Probe Sales, 2016-2027
  6.6.3 China RNA Probe Market Size, 2016-2027
  6.6.4 Japan RNA Probe Market Size, 2016-2027
  6.6.5 South Korea RNA Probe Market Size, 2016-2027
  6.6.6 Southeast Asia RNA Probe Market Size, 2016-2027
  6.6.7 India RNA Probe Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America RNA Probe Revenue, 2016-2027
  6.7.2 By Country - South America RNA Probe Sales, 2016-2027
  6.7.3 Brazil RNA Probe Market Size, 2016-2027
  6.7.4 Argentina RNA Probe Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa RNA Probe Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa RNA Probe Sales, 2016-2027
  6.8.3 Turkey RNA Probe Market Size, 2016-2027
  6.8.4 Israel RNA Probe Market Size, 2016-2027
  6.8.5 Saudi Arabia RNA Probe Market Size, 2016-2027
  6.8.6 UAE RNA Probe Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 Agilent Technologies
  7.1.1 Agilent Technologies Corporate Summary
  7.1.2 Agilent Technologies Business Overview
  7.1.3 Agilent Technologies RNA Probe Major Product Offerings
  7.1.4 Agilent Technologies RNA Probe Sales and Revenue in Global (2016-2021)
  7.1.5 Agilent Technologies Key News
7.2 Abnova Corporation
  7.2.1 Abnova Corporation Corporate Summary
  7.2.2 Abnova Corporation Business Overview
  7.2.3 Abnova Corporation RNA Probe Major Product Offerings
  7.2.4 Abnova Corporation RNA Probe Sales and Revenue in Global (2016-2021)
  7.2.5 Abnova Corporation Key News
7.3 Promega
  7.3.1 Promega Corporate Summary
  7.3.2 Promega Business Overview
  7.3.3 Promega RNA Probe Major Product Offerings
  7.3.4 Promega RNA Probe Sales and Revenue in Global (2016-2021)
  7.3.5 Promega Key News
7.4 Vermicon
  7.4.1 Vermicon Corporate Summary
  7.4.2 Vermicon Business Overview
  7.4.3 Vermicon RNA Probe Major Product Offerings
  7.4.4 Vermicon RNA Probe Sales and Revenue in Global (2016-2021)
  7.4.5 Vermicon Key News
7.5 Bio-Techne
  7.5.1 Bio-Techne Corporate Summary
  7.5.2 Bio-Techne Business Overview
  7.5.3 Bio-Techne RNA Probe Major Product Offerings
  7.5.4 Bio-Techne RNA Probe Sales and Revenue in Global (2016-2021)
  7.5.5 Bio-Techne Key News
7.6 Sigma-Aldrich
  7.6.1 Sigma-Aldrich Corporate Summary
  7.6.2 Sigma-Aldrich Business Overview
  7.6.3 Sigma-Aldrich RNA Probe Major Product Offerings
  7.6.4 Sigma-Aldrich RNA Probe Sales and Revenue in Global (2016-2021)
  7.6.5 Sigma-Aldrich Key News
7.7 Biolegio
  7.7.1 Biolegio Corporate Summary
  7.7.2 Biolegio Business Overview
  7.7.3 Biolegio RNA Probe Major Product Offerings
  7.4.4 Biolegio RNA Probe Sales and Revenue in Global (2016-2021)
  7.7.5 Biolegio Key News
7.8 Bioline
  7.8.1 Bioline Corporate Summary
  7.8.2 Bioline Business Overview
  7.8.3 Bioline RNA Probe Major Product Offerings
  7.8.4 Bioline RNA Probe Sales and Revenue in Global (2016-2021)
  7.8.5 Bioline Key News
7.9 Empire Genomics
  7.9.1 Empire Genomics Corporate Summary
  7.9.2 Empire Genomics Business Overview
  7.9.3 Empire Genomics RNA Probe Major Product Offerings
  7.9.4 Empire Genomics RNA Probe Sales and Revenue in Global (2016-2021)
  7.9.5 Empire Genomics Key News
7.10 QIAGEN
  7.10.1 QIAGEN Corporate Summary
  7.10.2 QIAGEN Business Overview
  7.10.3 QIAGEN RNA Probe Major Product Offerings
  7.10.4 QIAGEN RNA Probe Sales and Revenue in Global (2016-2021)
  7.10.5 QIAGEN Key News
7.11 Roche
  7.11.1 Roche Corporate Summary
  7.11.2 Roche RNA Probe Business Overview
  7.11.3 Roche RNA Probe Major Product Offerings
  7.11.4 Roche RNA Probe Sales and Revenue in Global (2016-2021)
  7.11.5 Roche Key News

8 GLOBAL RNA PROBE PRODUCTION CAPACITY, ANALYSIS

8.1 Global RNA Probe Production Capacity, 2016-2027
8.2 RNA Probe Production Capacity of Key Manufacturers in Global Market
8.3 Global RNA Probe Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 RNA PROBE SUPPLY CHAIN ANALYSIS

10.1 RNA Probe Industry Value Chain
10.2 RNA Probe Upstream Market
10.3 RNA Probe Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 RNA Probe Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES

Table 1. Immunohistochemistry (IHC) Testing Market Opportunities & Trends in Global Market
Table 2. Immunohistochemistry (IHC) Testing Market Drivers in Global Market
Table 3. Immunohistochemistry (IHC) Testing Market Restraints in Global Market
Table 4. Key Players of Immunohistochemistry (IHC) Testing in Global Market
Table 5. Top Immunohistochemistry (IHC) Testing Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Immunohistochemistry (IHC) Testing Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Immunohistochemistry (IHC) Testing Revenue Share by Companies, 2016-2021
Table 8. Global Companies Immunohistochemistry (IHC) Testing Product Type
Table 9. List of Global Tier 1 Immunohistochemistry (IHC) Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immunohistochemistry (IHC) Testing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Immunohistochemistry (IHC) Testing Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Immunohistochemistry (IHC) Testing Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Immunohistochemistry (IHC) Testing Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Immunohistochemistry (IHC) Testing Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Immunohistochemistry (IHC) Testing Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Immunohistochemistry (IHC) Testing Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2022-2027
Table 30. University of Texas MD Anderson Cancer Center Corporate Summary
Table 31. University of Texas MD Anderson Cancer Center Immunohistochemistry (IHC) Testing Product Offerings
Table 32. University of Texas MD Anderson Cancer Center Immunohistochemistry (IHC) Testing Revenue (US$, Mn), (2016-2021)
Table 33. Memorial Sloan Kettering Cancer Center Corporate Summary
Table 34. Memorial Sloan Kettering Cancer Center Immunohistochemistry (IHC) Testing Product Offerings
Table 35. Memorial Sloan Kettering Cancer Center Immunohistochemistry (IHC) Testing Revenue (US$, Mn), (2016-2021)
Table 36. Mayo Clinic Corporate Summary
Table 37. Mayo Clinic Immunohistochemistry (IHC) Testing Product Offerings
Table 38. Mayo Clinic Immunohistochemistry (IHC) Testing Revenue (US$, Mn), (2016-2021)
Table 39. Johns Hopkins Hospital Corporate Summary
Table 40. Johns Hopkins Hospital Immunohistochemistry (IHC) Testing Product Offerings
Table 41. Johns Hopkins Hospital Immunohistochemistry (IHC) Testing Revenue (US$, Mn), (2016-2021)
Table 42. Cleveland Clinic Corporate Summary
Table 43. Cleveland Clinic Immunohistochemistry (IHC) Testing Product Offerings
Table 44. Cleveland Clinic Immunohistochemistry (IHC) Testing Revenue (US$, Mn), (2016-2021)
Table 45. Dana-Farber/Brigham and Women's Cancer Center Corporate Summary
Table 46. Dana-Farber/Brigham and Women's Cancer Center Immunohistochemistry (IHC) Testing Product Offerings
Table 47. Dana-Farber/Brigham and Women's Cancer Center Immunohistochemistry (IHC) Testing Revenue (US$, Mn), (2016-2021)
Table 48. Cedars-Sinai Medical Center Corporate Summary
Table 49. Cedars-Sinai Medical Center Immunohistochemistry (IHC) Testing Product Offerings
Table 50. Cedars-Sinai Medical Center Immunohistochemistry (IHC) Testing Revenue (US$, Mn), (2016-2021)
Table 51. Northwestern Memorial Hospital Corporate Summary
Table 52. Northwestern Memorial Hospital Immunohistochemistry (IHC) Testing Product Offerings
Table 53. Northwestern Memorial Hospital Immunohistochemistry (IHC) Testing Revenue (US$, Mn), (2016-2021)
Table 54. Seattle Cancer Care Alliance/University of Washington Medical Center Corporate Summary
Table 55. Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry (IHC) Testing Product Offerings
Table 56. Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry (IHC) Testing Revenue (US$, Mn), (2016-2021)
Table 57. University of California San Francisco Medical Center Corporate Summary
Table 58. University of California San Francisco Medical Center Immunohistochemistry (IHC) Testing Product Offerings
Table 59. University of California San Francisco Medical Center Immunohistochemistry (IHC) Testing Revenue (US$, Mn), (2016-2021)
Table 60. CancerResearchUK Corporate Summary
Table 61. CancerResearchUK Immunohistochemistry (IHC) Testing Product Offerings
Table 62. CancerResearchUK Immunohistochemistry (IHC) Testing Revenue (US$, Mn), (2016-2021)
Table 63. Pfizer Corporate Summary
Table 64. Pfizer Immunohistochemistry (IHC) Testing Product Offerings
Table 65. Pfizer Immunohistochemistry (IHC) Testing Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Immunohistochemistry (IHC) Testing Segment by Type
Figure 2. Immunohistochemistry (IHC) Testing Segment by Application
Figure 3. Global Immunohistochemistry (IHC) Testing Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Immunohistochemistry (IHC) Testing Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Immunohistochemistry (IHC) Testing Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immunohistochemistry (IHC) Testing Revenue in 2020
Figure 8. By Type - Global Immunohistochemistry (IHC) Testing Revenue Market Share, 2016-2027
Figure 9. By Application - Global Immunohistochemistry (IHC) Testing Revenue Market Share, 2016-2027
Figure 10. By Region - Global Immunohistochemistry (IHC) Testing Revenue Market Share, 2016-2027
Figure 11. By Country - North America Immunohistochemistry (IHC) Testing Revenue Market Share, 2016-2027
Figure 12. US Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Immunohistochemistry (IHC) Testing Revenue Market Share, 2016-2027
Figure 16. Germany Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 17. France Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Immunohistochemistry (IHC) Testing Revenue Market Share, 2016-2027
Figure 24. China Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 28. India Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Immunohistochemistry (IHC) Testing Revenue Market Share, 2016-2027
Figure 30. Brazil Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Immunohistochemistry (IHC) Testing Revenue Market Share, 2016-2027
Figure 33. Turkey Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Immunohistochemistry (IHC) Testing Revenue, (US$, Mn), 2016-2027
Figure 37. University of Texas MD Anderson Cancer Center Immunohistochemistry (IHC) Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Memorial Sloan Kettering Cancer Center Immunohistochemistry (IHC) Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Mayo Clinic Immunohistochemistry (IHC) Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Johns Hopkins Hospital Immunohistochemistry (IHC) Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Cleveland Clinic Immunohistochemistry (IHC) Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Dana-Farber/Brigham and Women's Cancer Center Immunohistochemistry (IHC) Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Cedars-Sinai Medical Center Immunohistochemistry (IHC) Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Northwestern Memorial Hospital Immunohistochemistry (IHC) Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Seattle Cancer Care Alliance/University of Washington Medical Center Immunohistochemistry (IHC) Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. University of California San Francisco Medical Center Immunohistochemistry (IHC) Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. CancerResearchUK Immunohistochemistry (IHC) Testing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications